InstalabDexamethasone
Should you take a Dexamethasone test?
This test is most useful if any of these apply to you.
About Dexamethasone
An abnormal cortisol result after an overnight suppression test can have several explanations. Your body may be producing excess cortisol, too little of the test drug may have reached your bloodstream, or another condition may have affected the result. Measuring dexamethasone alongside cortisol helps identify problems with drug exposure before you draw conclusions about cortisol production.
What the Drug Level Measures
Dexamethasone is a synthetic corticosteroid with stronger and longer-lasting effects than cortisol. Your adrenal glands make cortisol, which helps regulate blood sugar, inflammation, and your response to stress. Dexamethasone comes from medication.
This test measures dexamethasone in serum and reports the concentration in ng/dL. Serum is the liquid left after blood clots. The result reflects the dose, how much was absorbed, how quickly your body clears the drug, and the time between taking it and collecting blood. It cannot separate those influences by itself.
Serum dexamethasone is a clinically used companion measurement for suppression testing. Published studies support its diagnostic usefulness, but interpretation remains specific to the laboratory and testing protocol. It has no established role as a standalone measure of everyday stress, biological aging, or adrenal health.
How Cortisol Suppression Works
The overnight dexamethasone suppression test examines how cortisol production responds to a steroid signal. ACTH is a hormone released by the pituitary gland that stimulates the adrenal glands to make cortisol. Dexamethasone normally reduces ACTH release, so cortisol falls.
Cortisol may fail to suppress when an adrenal growth produces it independently or when a pituitary or other tumor produces excess ACTH. A milder form of independent cortisol production can occur with adrenal nodules without the typical physical signs of Cushing syndrome. This is called mild autonomous cortisol secretion, or MACS. The overnight test alone does not establish where excess cortisol originates.
Evidence for Checking Drug Exposure
Studies measuring serum dexamethasone alongside cortisol have shown that limited drug exposure can explain some apparently abnormal suppression results. Their findings depend on the populations studied and the laboratory methods used.
| Who Was Studied | What Was Evaluated | What They Found |
|---|---|---|
| 400 serum samples from people with confirmed or excluded Cushing syndrome and people with adrenal incidentalomas | Excluding samples with inadequate dexamethasone AND changing the cortisol interpretation to match the assay | The proportion correctly classified among people without Cushing syndrome rose from 67.5% to 92.4%, while all evaluable Cushing cases were detected. The improvement cannot be attributed to measuring dexamethasone alone. |
| 302 participants, including people investigated for cortisol excess and healthy controls | Interpreting serum cortisol together with serum dexamethasone | False-positive suppression results fell by about a fifth. A separate group of 58 participants supported the findings. |
| 1,300 overnight suppression tests at one center | The frequency of inadequate serum dexamethasone exposure | About 1 in 9 tests had inadequate exposure by that laboratory's criteria. Associated factors included missed doses, interacting medicines, and gastrointestinal conditions. |
The frequency of inadequate exposure varies across studies. A later study of 636 overnight tests found very low drug concentrations uncommon and supported selective measurement when adherence, drug interactions, or conflicting results raised concern. Some people with low dexamethasone still had confirmed cortisol excess.
What Your Result Can Establish
A dexamethasone result can help establish whether drug exposure was consistent with the prescribed suppression protocol. A low result offers a possible explanation for cortisol failing to suppress, but it neither proves that the cortisol result is false nor excludes an underlying cortisol disorder.
Adequate exposure removes one source of uncertainty. Other causes of misleading cortisol results remain. A higher dexamethasone concentration is also not a health goal: unusually high exposure from an interacting medicine or an incorrect dose can exaggerate suppression and sometimes produce a falsely reassuring cortisol result.
Older age and higher BMI were associated with higher serum dexamethasone in a study of 546 people. Those associations do not establish how an individual result should be adjusted. Within that study, higher concentrations after adequate exposure was reached were not associated with further cortisol suppression.
Why the Cortisol Result Matters
The outcome evidence concerns cortisol after dexamethasone, a different measurement from the drug concentration itself. In an international cohort of 3,656 people with adrenal nodules, followed for a median of seven years, the group classified as having possible autonomous cortisol secretion had about 50% higher adjusted mortality than the group with nonfunctioning nodules. The group classified as having autonomous secretion had about 77% higher mortality. These were associations, and the study did not establish that adding a dexamethasone measurement improves survival.
Among women younger than 65 with autonomous secretion, the estimated mortality rate was about 4.4 times that of women with nonfunctioning nodules, though this subgroup estimate was imprecise. High blood pressure, diabetes, and abnormal blood fats were also more common in the groups with cortisol autonomy.
When Results Can Be Misleading
- Dose and collection timing: a missed dose, an incorrect dose, or blood collected outside the planned interval changes the meaning of the drug concentration. A late dose can leave more drug in the morning sample while allowing less time for cortisol suppression.
- Absorption problems: vomiting, chronic diarrhea, and some gastrointestinal conditions or operations can reduce exposure to the oral dose. A low concentration does not identify which of these occurred.
- Drug interactions: phenytoin, carbamazepine, and rifampicin can speed dexamethasone breakdown. Itraconazole and aprepitant can slow it. These interactions can alter the suppression test without causing an adrenal tumor or autonomous cortisol production.
- Other steroid exposure: recent dexamethasone treatment can contribute to the measured concentration. Other steroid medicines can suppress your own cortisol or interfere with some cortisol assays.
- Cortisol-binding proteins: oral estrogen can raise total serum cortisol by increasing its carrier protein. Low carrier-protein or albumin levels can make total cortisol appear lower. Adequate dexamethasone does not correct these effects.
- Kidney or liver disease: advanced kidney disease can prolong cortisol clearance, and some cortisol assays can overestimate the concentration in this setting. Liver disease can alter dexamethasone clearance. These conditions need to be considered even when the drug result appears adequate.
- Other causes of cortisol elevation: depression, heavy alcohol use, poorly controlled diabetes, and serious illness can produce abnormal cortisol testing without tumor-related Cushing syndrome.
- Laboratory differences: dexamethasone and cortisol are separate measurements, each with its own analytical limitations. Results require interpretation using the performing laboratory's method and the actual dose and collection times; the drug result cannot rule out an error in the cortisol measurement.
Understanding Repeat Results
Each dexamethasone result describes exposure during a particular test. A change between tests can reflect medication changes, dose timing, absorption, or clearance. It does not establish that your adrenal condition has improved or worsened, and a previous adequate result does not guarantee the same exposure on another occasion.